+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Allergy Immunotherapies Market 2024-2028

  • PDF Icon

    Report

  • 167 Pages
  • May 2024
  • Region: Global
  • TechNavio
  • ID: 5008937
1h Free Analyst Time
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The allergy immunotherapies market is forecasted to grow byUSD 1.18 billion during 2023-2028, accelerating at a CAGR of 9.62% during the forecast period. The report on the allergy immunotherapies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by increasing prevalence of allergies, recent approvals and a strong pipeline, and growing market consolidation.

The allergy immunotherapies market is segmented as below:

By Product

  • SCIT
  • SLIT

By Type

  • Allergic Rhinitis
  • Asthma
  • Food Allergy
  • Others

By Geographical Landscape

  • Europe
  • North America
  • Asia
  • Rest of World (ROW)
This study identifies the technological advances in allergy diagnostics as one of the prime reasons driving the allergy immunotherapies market growth during the next few years. Also, emerging drug development technologies and growing popularity of slit will lead to sizable demand in the market.

The report on the allergy immunotherapies market covers the following areas:

  • Allergy immunotherapies market sizing
  • Allergy immunotherapies market forecast
  • Allergy immunotherapies market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading allergy immunotherapies market vendors that include Adamis Pharmaceuticals Corp., Aimmune Therapeutics Inc., ALK Abello AS, ALLERGOPHARMA GmbH and Co. KG, Allergy Therapeutics PLC‚, Biomay AG, DBV Technologies SA, Desentum Oy, HAL Allergy BV, Immunomic Therapeutics Inc., Jubilant Pharmova Ltd., LETI Pharma SLU, LOFARMA Spa, Merck KGaA, Novartis AG, Optum Inc., SHIONOGI Co. Ltd., Stallergenes Greer Ltd., Torii Pharmaceutical Co. Ltd., and Viatris Inc.. Also, the allergy immunotherapies market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The report presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market By Geographical Landscape
Executive Summary - Chart on Market Segmentation by Product
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning
2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis
3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)
4 Historic Market Size
4.1 Global Allergy Immunotherapies Market 2018 - 2022
Historic Market Size - Data Table on Global Allergy Immunotherapies Market 2018 - 2022 ($ million)
4.2 Product segment analysis 2018 - 2022
Historic Market Size - Product Segment 2018 - 2022 ($ million)
4.3 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.4 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.5 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)
5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028
6 Market Segmentation by Product
6.1 Market segments
Chart on Product - Market share 2023-2028 (%)
Data Table on Product - Market share 2023-2028 (%)
6.2 Comparison by Product
Chart on Comparison by Product
Data Table on Comparison by Product
6.3 SCIT - Market size and forecast 2023-2028
Chart on SCIT - Market size and forecast 2023-2028 ($ million)
Data Table on SCIT - Market size and forecast 2023-2028 ($ million)
Chart on SCIT - Year-over-year growth 2023-2028 (%)
Data Table on SCIT - Year-over-year growth 2023-2028 (%)
6.4 SLIT - Market size and forecast 2023-2028
Chart on SLIT - Market size and forecast 2023-2028 ($ million)
Data Table on SLIT - Market size and forecast 2023-2028 ($ million)
Chart on SLIT - Year-over-year growth 2023-2028 (%)
Data Table on SLIT - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Product
Market opportunity by Product ($ million)
Data Table on Market opportunity by Product ($ million)
7 Market Segmentation by Type
7.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
7.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
7.3 Allergic Rhinitis - Market size and forecast 2023-2028
Chart on Allergic Rhinitis - Market size and forecast 2023-2028 ($ million)
Data Table on Allergic Rhinitis - Market size and forecast 2023-2028 ($ million)
Chart on Allergic Rhinitis - Year-over-year growth 2023-2028 (%)
Data Table on Allergic Rhinitis - Year-over-year growth 2023-2028 (%)
7.4 Asthma - Market size and forecast 2023-2028
Chart on Asthma - Market size and forecast 2023-2028 ($ million)
Data Table on Asthma - Market size and forecast 2023-2028 ($ million)
Chart on Asthma - Year-over-year growth 2023-2028 (%)
Data Table on Asthma - Year-over-year growth 2023-2028 (%)
7.5 Food Allergy - Market size and forecast 2023-2028
Chart on Food Allergy - Market size and forecast 2023-2028 ($ million)
Data Table on Food Allergy - Market size and forecast 2023-2028 ($ million)
Chart on Food Allergy - Year-over-year growth 2023-2028 (%)
Data Table on Food Allergy - Year-over-year growth 2023-2028 (%)
7.6 Others - Market size and forecast 2023-2028
Chart on Others - Market size and forecast 2023-2028 ($ million)
Data Table on Others - Market size and forecast 2023-2028 ($ million)
Chart on Others - Year-over-year growth 2023-2028 (%)
Data Table on Others - Year-over-year growth 2023-2028 (%)
7.7 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)
8 Customer Landscape
8.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
9.1 Geographic segmentation
Chart on Market share By Geographical Landscape 2023-2028 (%)
Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
9.3 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.4 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.8 France - Market size and forecast 2023-2028
Chart on France - Market size and forecast 2023-2028 ($ million)
Data Table on France - Market size and forecast 2023-2028 ($ million)
Chart on France - Year-over-year growth 2023-2028 (%)
Data Table on France - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
9.11 Japan - Market size and forecast 2023-2028
Chart on Japan - Market size and forecast 2023-2028 ($ million)
Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Chart on Japan - Year-over-year growth 2023-2028 (%)
Data Table on Japan - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Market opportunity By Geographical Landscape ($ million)
Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Opportunity/Restraints
10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
10.4 Market opportunities/restraints
11 Competitive Landscape
11.1 Overview
11.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
11.3 Landscape disruption
Overview on factors of disruption
11.4 Industry risks
Impact of key risks on business
12 Competitive Analysis
12.1 Companies profiled
Companies covered
12.2 Market positioning of companies
Matrix on companies position and classification
12.3 Adamis Pharmaceuticals Corp.
Adamis Pharmaceuticals Corp. - Overview
Adamis Pharmaceuticals Corp. - Business segments
Adamis Pharmaceuticals Corp. - Key offerings
Adamis Pharmaceuticals Corp. - Segment focus
12.4 Aimmune Therapeutics Inc.
Aimmune Therapeutics Inc. - Overview
Aimmune Therapeutics Inc. - Product / Service
Aimmune Therapeutics Inc. - Key offerings
12.5 ALK Abello AS
ALK Abello AS - Overview
ALK Abello AS - Business segments
ALK Abello AS - Key offerings
ALK Abello AS - Segment focus
12.6 Allergy Therapeutics PLC
Allergy Therapeutics PLC - Overview
Allergy Therapeutics PLC - Product / Service
Allergy Therapeutics PLC - Key offerings
12.7 DBV Technologies SA
DBV Technologies SA - Overview
DBV Technologies SA - Product / Service
DBV Technologies SA - Key offerings
12.8 Desentum Oy
Desentum Oy - Overview
Desentum Oy - Product / Service
Desentum Oy - Key offerings
12.9 HAL Allergy BV
HAL Allergy BV - Overview
HAL Allergy BV - Key offerings
12.10 Immunomic Therapeutics Inc.
Immunomic Therapeutics Inc. - Overview
Immunomic Therapeutics Inc. - Product / Service
Immunomic Therapeutics Inc. - Key offerings
12.11 Jubilant Pharmova Ltd.
Jubilant Pharmova Ltd. - Overview
Jubilant Pharmova Ltd. - Business segments
Jubilant Pharmova Ltd. - Key offerings
Jubilant Pharmova Ltd. - Segment focus
12.12 LETI Pharma SLU
LETI Pharma SLU - Overview
LETI Pharma SLU - Product / Service
LETI Pharma SLU - Key offerings
12.13 LOFARMA Spa
LOFARMA Spa - Overview
LOFARMA Spa - Product / Service
LOFARMA Spa - Key offerings
12.14 Merck KGaA
Merck KGaA - Overview
Merck KGaA - Business segments
Merck KGaA - Key news
Merck KGaA - Key offerings
Merck KGaA - Segment focus
12.15 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
12.16 Stallergenes Greer Ltd.
Stallergenes Greer Ltd. - Overview
Stallergenes Greer Ltd. - Product / Service
Stallergenes Greer Ltd. - Key offerings
12.17 Viatris Inc.
Viatris Inc. - Overview
Viatris Inc. - Business segments
Viatris Inc. - Key news
Viatris Inc. - Key offerings
Viatris Inc. - Segment focus
13 Appendix
13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
13.3 Currency conversion rates for US$
Currency conversion rates for US$
13.4 Research methodology
Research methodology
13.5 Data procurement
Information sources
13.6 Data validation
Data validation
13.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
13.8 Data synthesis
Data synthesis
13.9 360 degree market analysis
360 degree market analysis
13.10 List of abbreviations
List of abbreviations
List of Exhibits
Exhibits 1: Executive Summary - Chart on Market Overview
Exhibits 2: Executive Summary - Data Table on Market Overview
Exhibits 3: Executive Summary - Chart on Global Market Characteristics
Exhibits 4: Executive Summary - Chart on Market By Geographical Landscape
Exhibits 5: Executive Summary - Chart on Market Segmentation by Product
Exhibits 6: Executive Summary - Chart on Market Segmentation by Type
Exhibits 7: Executive Summary - Chart on Incremental Growth
Exhibits 8: Executive Summary - Data Table on Incremental Growth
Exhibits 9: Executive Summary - Chart on Company Market Positioning
Exhibits 10: Parent Market
Exhibits 11: Data Table on - Parent Market
Exhibits 12: Market characteristics analysis
Exhibits 13: Value Chain Analysis
Exhibits 14: Offerings of companies included in the market definition
Exhibits 15: Market segments
Exhibits 16: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 17: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits 18: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 19: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits 20: Historic Market Size - Data Table on Global Allergy Immunotherapies Market 2018 - 2022 ($ million)
Exhibits 21: Historic Market Size - Product Segment 2018 - 2022 ($ million)
Exhibits 22: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits 23: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits 24: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits 25: Five forces analysis - Comparison between 2023 and 2028
Exhibits 26: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits 27: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits 28: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits 29: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits 30: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits 31: Chart on Market condition - Five forces 2023 and 2028
Exhibits 32: Chart on Product - Market share 2023-2028 (%)
Exhibits 33: Data Table on Product - Market share 2023-2028 (%)
Exhibits 34: Chart on Comparison by Product
Exhibits 35: Data Table on Comparison by Product
Exhibits 36: Chart on SCIT - Market size and forecast 2023-2028 ($ million)
Exhibits 37: Data Table on SCIT - Market size and forecast 2023-2028 ($ million)
Exhibits 38: Chart on SCIT - Year-over-year growth 2023-2028 (%)
Exhibits 39: Data Table on SCIT - Year-over-year growth 2023-2028 (%)
Exhibits 40: Chart on SLIT - Market size and forecast 2023-2028 ($ million)
Exhibits 41: Data Table on SLIT - Market size and forecast 2023-2028 ($ million)
Exhibits 42: Chart on SLIT - Year-over-year growth 2023-2028 (%)
Exhibits 43: Data Table on SLIT - Year-over-year growth 2023-2028 (%)
Exhibits 44: Market opportunity by Product ($ million)
Exhibits 45: Data Table on Market opportunity by Product ($ million)
Exhibits 46: Chart on Type - Market share 2023-2028 (%)
Exhibits 47: Data Table on Type - Market share 2023-2028 (%)
Exhibits 48: Chart on Comparison by Type
Exhibits 49: Data Table on Comparison by Type
Exhibits 50: Chart on Allergic Rhinitis - Market size and forecast 2023-2028 ($ million)
Exhibits 51: Data Table on Allergic Rhinitis - Market size and forecast 2023-2028 ($ million)
Exhibits 52: Chart on Allergic Rhinitis - Year-over-year growth 2023-2028 (%)
Exhibits 53: Data Table on Allergic Rhinitis - Year-over-year growth 2023-2028 (%)
Exhibits 54: Chart on Asthma - Market size and forecast 2023-2028 ($ million)
Exhibits 55: Data Table on Asthma - Market size and forecast 2023-2028 ($ million)
Exhibits 56: Chart on Asthma - Year-over-year growth 2023-2028 (%)
Exhibits 57: Data Table on Asthma - Year-over-year growth 2023-2028 (%)
Exhibits 58: Chart on Food Allergy - Market size and forecast 2023-2028 ($ million)
Exhibits 59: Data Table on Food Allergy - Market size and forecast 2023-2028 ($ million)
Exhibits 60: Chart on Food Allergy - Year-over-year growth 2023-2028 (%)
Exhibits 61: Data Table on Food Allergy - Year-over-year growth 2023-2028 (%)
Exhibits 62: Chart on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 63: Data Table on Others - Market size and forecast 2023-2028 ($ million)
Exhibits 64: Chart on Others - Year-over-year growth 2023-2028 (%)
Exhibits 65: Data Table on Others - Year-over-year growth 2023-2028 (%)
Exhibits 66: Market opportunity by Type ($ million)
Exhibits 67: Data Table on Market opportunity by Type ($ million)
Exhibits 68: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits 69: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 70: Data Table on Market share By Geographical Landscape 2023-2028 (%)
Exhibits 71: Chart on Geographic comparison
Exhibits 72: Data Table on Geographic comparison
Exhibits 73: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 74: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits 75: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 76: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits 77: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 78: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits 79: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits 80: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits 81: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 82: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits 83: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 84: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits 85: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 86: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits 87: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 88: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits 89: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 90: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits 91: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 92: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits 93: Chart on France - Market size and forecast 2023-2028 ($ million)
Exhibits 94: Data Table on France - Market size and forecast 2023-2028 ($ million)
Exhibits 95: Chart on France - Year-over-year growth 2023-2028 (%)
Exhibits 96: Data Table on France - Year-over-year growth 2023-2028 (%)
Exhibits 97: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 98: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits 99: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits 100: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits 101: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits 102: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits 103: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits 104: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits 105: Chart on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 106: Data Table on Japan - Market size and forecast 2023-2028 ($ million)
Exhibits 107: Chart on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 108: Data Table on Japan - Year-over-year growth 2023-2028 (%)
Exhibits 109: Market opportunity By Geographical Landscape ($ million)
Exhibits 110: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits 111: Impact of drivers and challenges in 2023 and 2028
Exhibits 112: Overview on criticality of inputs and factors of differentiation
Exhibits 113: Overview on factors of disruption
Exhibits 114: Impact of key risks on business
Exhibits 115: Companies covered
Exhibits 116: Matrix on companies position and classification
Exhibits 117: Adamis Pharmaceuticals Corp. - Overview
Exhibits 118: Adamis Pharmaceuticals Corp. - Business segments
Exhibits 119: Adamis Pharmaceuticals Corp. - Key offerings
Exhibits 120: Adamis Pharmaceuticals Corp. - Segment focus
Exhibits 121: Aimmune Therapeutics Inc. - Overview
Exhibits 122: Aimmune Therapeutics Inc. - Product / Service
Exhibits 123: Aimmune Therapeutics Inc. - Key offerings
Exhibits 124: ALK Abello AS - Overview
Exhibits 125: ALK Abello AS - Business segments
Exhibits 126: ALK Abello AS - Key offerings
Exhibits 127: ALK Abello AS - Segment focus
Exhibits 128: Allergy Therapeutics PLC - Overview
Exhibits 129: Allergy Therapeutics PLC - Product / Service
Exhibits 130: Allergy Therapeutics PLC - Key offerings
Exhibits 131: DBV Technologies SA - Overview
Exhibits 132: DBV Technologies SA - Product / Service
Exhibits 133: DBV Technologies SA - Key offerings
Exhibits 134: Desentum Oy - Overview
Exhibits 135: Desentum Oy - Product / Service
Exhibits 136: Desentum Oy - Key offerings
Exhibits 137: HAL Allergy BV - Overview
Exhibits 138: HAL Allergy BV - Key offerings
Exhibits 139: Immunomic Therapeutics Inc. - Overview
Exhibits 140: Immunomic Therapeutics Inc. - Product / Service
Exhibits 141: Immunomic Therapeutics Inc. - Key offerings
Exhibits 142: Jubilant Pharmova Ltd. - Overview
Exhibits 143: Jubilant Pharmova Ltd. - Business segments
Exhibits 144: Jubilant Pharmova Ltd. - Key offerings
Exhibits 145: Jubilant Pharmova Ltd. - Segment focus
Exhibits 146: LETI Pharma SLU - Overview
Exhibits 147: LETI Pharma SLU - Product / Service
Exhibits 148: LETI Pharma SLU - Key offerings
Exhibits 149: LOFARMA Spa - Overview
Exhibits 150: LOFARMA Spa - Product / Service
Exhibits 151: LOFARMA Spa - Key offerings
Exhibits 152: Merck KGaA - Overview
Exhibits 153: Merck KGaA - Business segments
Exhibits 154: Merck KGaA - Key news
Exhibits 155: Merck KGaA - Key offerings
Exhibits 156: Merck KGaA - Segment focus
Exhibits 157: Novartis AG - Overview
Exhibits 158: Novartis AG - Business segments
Exhibits 159: Novartis AG - Key news
Exhibits 160: Novartis AG - Key offerings
Exhibits 161: Novartis AG - Segment focus
Exhibits 162: Stallergenes Greer Ltd. - Overview
Exhibits 163: Stallergenes Greer Ltd. - Product / Service
Exhibits 164: Stallergenes Greer Ltd. - Key offerings
Exhibits 165: Viatris Inc. - Overview
Exhibits 166: Viatris Inc. - Business segments
Exhibits 167: Viatris Inc. - Key news
Exhibits 168: Viatris Inc. - Key offerings
Exhibits 169: Viatris Inc. - Segment focus
Exhibits 170: Inclusions checklist
Exhibits 171: Exclusions checklist
Exhibits 172: Currency conversion rates for US$
Exhibits 173: Research methodology
Exhibits 174: Information sources
Exhibits 175: Data validation
Exhibits 176: Validation techniques employed for market sizing
Exhibits 177: Data synthesis
Exhibits 178: 360 degree market analysis
Exhibits 179: List of abbreviations

Executive Summary

The following companies are recognized as the key players in the global allergy immunotherapies market: Adamis Pharmaceuticals Corp., Aimmune Therapeutics Inc., ALK Abello AS, ALLERGOPHARMA GmbH and Co. KG, Allergy Therapeutics PLC‚ , Biomay AG, DBV Technologies SA, Desentum Oy, HAL Allergy BV, Immunomic Therapeutics Inc., Jubilant Pharmova Ltd., LETI Pharma SLU, LOFARMA Spa, Merck KGaA, Novartis AG, Optum Inc., SHIONOGI Co. Ltd., Stallergenes Greer Ltd., Torii Pharmaceutical Co. Ltd., and Viatris Inc..

Commenting on the report, an analyst from the research team said: "The latest trend gaining momentum in the market is technological advances in allergy diagnostics."

According to the report, one of the major drivers for this market is the increasing prevalence of allergies.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Adamis Pharmaceuticals Corp.
  • Aimmune Therapeutics Inc.
  • ALK Abello AS
  • ALLERGOPHARMA GmbH and Co. KG
  • Allergy Therapeutics PLC‚
  • Biomay AG
  • DBV Technologies SA
  • Desentum Oy
  • HAL Allergy BV
  • Immunomic Therapeutics Inc.
  • Jubilant Pharmova Ltd.
  • LETI Pharma SLU
  • LOFARMA Spa
  • Merck KGaA
  • Novartis AG
  • Optum Inc.
  • SHIONOGI Co. Ltd.
  • Stallergenes Greer Ltd.
  • Torii Pharmaceutical Co. Ltd.
  • Viatris Inc.